Trials / Unknown
UnknownNCT03928964
MEtatastic Renal Carcinoma LINes
Pronostic Assessment of Mortality Among Locally Advanced or Metastatic Renal Cell Carcinoma Patients After First Line Treatment : Multicenter Prospective Cohort Study With Historic Medical Data
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 440 (estimated)
- Sponsor
- Centre Hospitalier Universitaire de Besancon · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The hypothesis of this study are as follows: * Prognostic evaluation of patients based on an integrative model provides better assessment of overall survival, and thus improves setting of care goals. * In a routine care population, antitumour drugs may have a significant impact on overall survival through their targeted antitumor effect, but also through their toxicity profile and their impact on comorbidities. * The optimization of patient support (supportive care, drug tolerance monitoring) can have an impact on the prognosis.
Conditions
Timeline
- Start date
- 2018-01-15
- Primary completion
- 2018-10-03
- Completion
- 2019-04-01
- First posted
- 2019-04-26
- Last updated
- 2019-04-30
Locations
8 sites across 1 country: France
Source: ClinicalTrials.gov record NCT03928964. Inclusion in this directory is not an endorsement.